$3.28 -$0.05 (-1.5%)

04:00 PM EST on 11/18/19

Acer Therapeutics Inc (NASDAQ:ACER)

CAPS Rating: 1 out of 5

A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

Current Price $3.28 Mkt Cap $33.1M
Open $3.28 P/E Ratio 0.00
Prev. Close $3.33 Div. (Yield) $0.00 (0.0%)
Daily Range $3.17 - $3.33 Volume 16,640
52-Wk Range $1.87 - $28.25 Avg. Daily Vol. 45,302


How do you think NASDAQ:ACER will perform against the market?

Add Stock to CAPS Watchlist

All Players

33 Outperform
25 Underperform

All-Star Players

4 Outperform
21 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:ACER Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

whoodatstockhot (83.63)
Submitted August 07, 2013

Cutting edge research being completed at Opexa, huge buyout potential here, one of those specs that could change how MS is treated. Balance sheet strong, low risk of secondary. Great risk reward, with over 500% upisde quite possible for long-term… More

jed71 (99.88)
Submitted November 07, 2016

Well, this certainly seems to shed light on some of their problems: "Opexa Therapeutics reduces workforce by 40% in light of the negative Phase 2b Abili-T clinical trial top-line results announced on October 28""Following further analysis of the… More


Fools bullish on NASDAQ:ACER are also bullish on:

Fools bearish on NASDAQ:ACER are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ACER.


Member Avatar jed71 (99.88) Submitted: 11/7/2016 10:24:32 AM : Underperform Start Price: $7.11 NASDAQ:ACER Score: +101.24

Well, this certainly seems to shed light on some of their problems:

"Opexa Therapeutics reduces workforce by 40% in light of the negative Phase 2b Abili-T clinical trial top-line results announced on October 28"

"Following further analysis of the Phase 2b Abili-T clinical trial top-line results and in order to reduce operating expenses and conserve cash resources, on October 26, 2016, the Company's Board of Directors approved reduction of the Company's 20 current full-time employees. The workforce reduction is effective immediately. The Company estimates that it will incur incremental aggregate cash charges of approximately $95,000 associated with this workforce reduction. The Company also announced that it had accepted the resignation of Donna Rill, the Company's Chief Development Officer, with such resignation to be effective as of November 4, 2016."

I expect a reverse split will follow shortly, as well as a new cash raise after the reverse split takes place. That's assuming they can find anyone to sell additional shares to, which seems to be a bit of a stretch here. A little more dangerous than my normal red thumbs, but this should move much lower over the next 12 months or so. Target under $0.10 pre-split.


Member Avatar allstar31 (99.89) Submitted: 9/12/2014 11:14:52 PM : Underperform Start Price: $111.01 NASDAQ:ACER Score: +153.72

Uses known stock pump and dumper Redchip.com for PR purposes. Garbage.


Member Avatar SqwiiTrader (< 20) Submitted: 11/15/2013 3:00:17 PM : Outperform Start Price: $189.70 NASDAQ:ACER Score: -171.79

One massive IHS on monhtly


Find the members with the highest scoring picks in ACER.

Score Leader


whatsthepoint (99.98) Score: +372.26

The Score Leader is the player with the highest score across all their picks in ACER.

Member Name Member
Call Time
Score Commentary
MaxPwr273 72.07 10/26/2011 Underperform 5Y $364.50 -99.10% +150.32% +249.43 0 Comment
2011Fool 96.37 2/18/2011 Underperform NS $632.90 -99.48% +132.22% +231.70 0 Comment
Halffrenzy 26.09 3/13/2013 Underperform 5Y $178.11 -98.16% +100.33% +198.49 0 Comment
saab93boi 20.76 3/26/2013 Underperform 3W $211.24 -98.45% +99.93% +198.38 0 Comment
Mary953 85.26 3/25/2013 4/6/2018 Underperform 5Y $173.14 -98.11% +100.01% +198.11 0 Comment
stockjock11 24.34 5/22/2013 Underperform 5Y $138.34 -97.63% +85.16% +182.79 0 Comment
allstar31 99.89 9/15/2014 Underperform 5Y $111.01 -97.05% +56.67% +153.72 1 Comment
zzlangerhans 99.79 10/31/2016 Underperform 1Y $8.80 -62.73% +46.80% +109.53 0 Comment
thehammer01 97.88 11/30/2016 Underperform 5Y $9.73 -66.31% +41.38% +107.69 0 Comment
johnnyrocku 99.89 10/16/2017 Underperform 5Y $18.69 -82.45% +22.36% +104.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ACER.